F
$ Value
$658K
Shares
69,288
Price
$9
Filed
Mar 5
Insider
Name
Jacobs John C
Title
President and CEO
CIK
0001820836
Roles
Director
Officer
Transaction Details
Transaction Date
2026-03-03
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
225,680
Footnotes
Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. | One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date.
Filing Info
Jacobs John C's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-03 | NVAX | M | $0 |
| 2026-03-03 | NVAX | F | $658K |
| 2026-03-03 | NVAX | M | $0 |
| 2026-03-02 | NVAX | A | $0 |
| 2026-03-02 | NVAX | A | $0 |
| 2026-03-01 | NVAX | M | $0 |
| 2026-03-01 | NVAX | F | $390K |
| 2026-03-01 | NVAX | M | $0 |
| 2026-01-23 | NVAX | M | $0 |
| 2026-01-23 | NVAX | F | $359K |
Other Insiders at NVAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Casey Mark J
EVP, Chief Legal Officer
|
— | — | 2026-03-03 |
|
Kelly James Patrick
EVP, CFO and Treasurer
|
— | — | 2026-03-07 |
|
Jacobs John C
President and CEO
|
— | — | 2026-03-03 |
| Shiver John W. | — | — | 2026-03-10 |
|
O'Hara Elaine
EVP, Chief Strategy Officer
|
— | — | 2026-03-03 |
|
Draghia-Akli Ruxandra
EVP, Research & Development
|
— | — | 2026-03-03 |
|
Walker Robert Edward
EVP, R&D
|
— | — | 2026-04-14 |